STAAR Surgical Repots Preliminary Net Sales Of $76.5M (est. $74.23M) For Q4 And Approximately $322.5M (Est. $320.5M) For FY23
Portfolio Pulse from Benzinga Newsdesk
STAAR Surgical reported preliminary net sales of $76.5 million for Q4, surpassing estimates of $74.23 million. For the full year 2023, the company expects approximately $322.5 million in net sales, slightly above the estimated $320.5 million.
January 08, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
STAAR Surgical's Q4 sales exceeded expectations and the company's FY23 sales forecast also surpassed estimates, indicating strong financial performance.
Beating quarterly sales estimates and providing a higher-than-expected annual forecast typically have a positive impact on a company's stock price in the short term. Investors may react favorably to STAAR Surgical's financial performance, which could lead to an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100